Equillium Correlations
EQ Stock | USD 0.77 0.02 2.67% |
The current 90-days correlation between Equillium and Hookipa Pharma is 0.04 (i.e., Significant diversification). The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Equillium Correlation With Market
Good diversification
The correlation between Equillium and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and DJI in the same portfolio, assuming nothing else is changed.
Equillium |
Moving together with Equillium Stock
0.63 | VALN | Valneva SE ADR Earnings Call Today | PairCorr |
0.64 | VIGL | Vigil Neuroscience | PairCorr |
0.65 | KTTAW | Pasithea Therapeutics | PairCorr |
0.72 | VTVT | vTv Therapeutics Trending | PairCorr |
Moving against Equillium Stock
0.5 | SABSW | SAB Biotherapeutics | PairCorr |
0.48 | DRRX | Durect Earnings Call This Week | PairCorr |
0.47 | DRTS | Alpha Tau Medical | PairCorr |
0.43 | VERA | Vera Therapeutics | PairCorr |
0.35 | DSGN | Design Therapeutics | PairCorr |
0.34 | VINC | Vincerx Pharma | PairCorr |
0.33 | ME | 23Andme Holding | PairCorr |
0.5 | VYGR | Voyager Therapeutics | PairCorr |
0.36 | VRDN | Viridian Therapeutics | PairCorr |
0.32 | VTYX | Ventyx Biosciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Equillium Stock performing well and Equillium Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Equillium's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LYRA | 2.90 | (0.21) | 0.00 | (0.83) | 0.00 | 5.56 | 25.31 | |||
HOOK | 3.67 | (0.99) | 0.00 | (3.33) | 0.00 | 7.00 | 32.80 | |||
LIAN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
JSPR | 4.90 | (1.53) | 0.00 | 10.22 | 0.00 | 8.23 | 68.83 | |||
CINGW | 14.57 | 2.80 | 0.13 | 0.30 | 14.84 | 41.67 | 106.22 | |||
SABS | 5.36 | (0.97) | 0.00 | (1.35) | 0.00 | 11.72 | 71.75 | |||
ANEB | 5.11 | 0.40 | 0.06 | 0.18 | 5.31 | 19.58 | 40.87 | |||
CVKD | 4.20 | 0.88 | 0.18 | 3.31 | 4.54 | 11.37 | 24.29 | |||
MNPR | 6.36 | 1.01 | 0.13 | 4.18 | 7.34 | 15.06 | 38.32 | |||
SPRO | 2.53 | (0.50) | 0.00 | (1.38) | 0.00 | 4.85 | 21.98 |
Equillium Corporate Management
Jason Keyes | Chief Officer | Profile | |
Matthew Ritter | Senior Development | Profile | |
Penny Tom | Principal Officer | Profile | |
Maple MD | Chief Officer | Profile | |
Krishna MD | Consultant | Profile |